Association Rate Constant: The Unsung Hero of Drug Discovery Kinetics

VIEW NOW Broadcast Date: May 21, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET While the importance of ligand-receptor binding kinetics on drug action is...

Self-Amplifying mRNA Vaccines for Pandemic Rapid Response

In this GEN webinar, sponsored by TriLink Biotechnologies, we will hear about data innovations from seven years of research at Novartis Vaccines on self-amplifying mRNA technology and how this approach could enable the concept of vaccines on demand as a rapid response to a real threat rather that the deployment of strategic stockpiles based on epidemiological predictions of a possible threat.

Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M

Grünenthal has agreed to acquire AstraZeneca's European rights to Nexium®(esomeprazole) and the pharma giant’s rights to Vimovo® (naproxen/esomeprazole) worldwide except the U.S. and Japan...

Parkinson’s Disease Drug That Cools “Brains on Fire” Could Enter Human...

Researchers at the University of Queensland in Australia have identified a small molecule that can stop the progression of Parkinson’s disease (PD) and improve...

Zika’s Balloon Popped by Peptide Needle

A new antiviral drug candidate attacks the Zika virus where it may be most vulnerable—the lipid membrane, which envelopes Zika’s RNA payload. The drug...

Conjoined Cells Form a Potent Immunotherapy Combo

Shackled together, stem cells and platelets may help us escape cancer, report UCLA scientists. In the scientists’ new study, the cancer is leukemia, and...

Custom Manufacturing Accelerates Time to Market

As the life science industry faces increasing competition—as well as global regulatory and pricing pressures—outsourcing portions or all of manufacturing is becoming increasingly prevalent....

Pergamum and Cadila Collaborate on Novel Therapy for Infections

Pergamum agreed to collaborate with Cadila Pharmaceuticals to develop a new treatment for infections based on a novel targeting mechanism that is different from classical antibiotic therapy.

Targeting Glioblastoma by Depriving Brain Cancer Cells of Cholesterol

Study identified a metabolic vulnerability in the aggressive and incurable brain cancer glioblastoma and shown how it can potentially be exploited for therapy.

Win More Biologics Development Battles with Early Stability Analysis

Broadcast Date: June 21st, 2017 Time: 11:00 am ET, 8:00 am PT Biophysical and chemical properties are critical factors that can dictate success or failure in...

Recently Featured

Scroll Up